Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Perrigo Company PLC (NYSE:PRGO)

77.80
Delayed Data
As of Jan 13
 -0.38 / -0.49%
Today’s Change
76.08
Today|||52-Week Range
152.36
-6.52%
Year-to-Date
Memo to Paul Price on Fastenal
Jan 13 / TheStreet.com - Paid Partner Content
Valeant's CEO Tries to Pitch Wall Street On the 'New Valeant' Being Very Different
Jan 11 / TheStreet.com - Paid Partner Content
Why Perrigo, Novadaq Technologies, and Ethan Allen Interiors Slumped Today
Jan 11 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close78.18
Today’s open78.40
Day’s range77.75 - 79.34
Volume1,527,759
Average volume (3 months)1,815,152
Market cap$11.2B
Dividend yield0.75%
Data as of 4:02pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)-95.67%
Earnings growth (this year)--
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+36.36%
P/E ratio16.4
Price/Sales3.82
Price/Book1.11

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc+0.81+1.48%
SGENSeattle Genetics Inc+0.26+0.44%
TSROTESARO Inc+9.43+6.42%
RDYDr.Reddy's Laborator...+0.18+0.41%
Data as of 4:02pm ET, 01/13/2017

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)$1.64
Annual revenue (last year)$5.5B
Annual profit (last year)$11.2M
Net profit margin0.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
John T. Hendrickson
Executive VP, Chief Financial &
Accounting Officer
Judy L. Brown
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs